Indication
Gait Impairment
2 clinical trials
2 products
1 drug
Clinical trial
1/2-Dopaminergic Dysfunction in Late-Life Depression (The D3 Study)Status: Terminated, Estimated PCD: 2021-10-27
Product
Carbidopa/levodopaDrug
VarlilumabClinical trial
Dopaminergic Dysfunction in Late-Life DepressionStatus: Recruiting, Estimated PCD: 2025-04-30
Product
L-Dopa